• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur Radiol. Evolution of CT findings in patients with mild COVID-19 pneumonia

tetano

Editor, Senior Moderator
Eur Radiol. 2020 Apr 15. doi: 10.1007/s00330-020-06823-8. [Epub ahead of print]
Evolution of CT findings in patients with mild COVID-19 pneumonia.


Liang T[SUP]1[/SUP], Liu Z[SUP]1[/SUP], Wu CC[SUP]2[/SUP], Jin C[SUP]1[/SUP], Zhao H[SUP]1[/SUP], Wang Y[SUP]1[/SUP], Wang Z[SUP]3[/SUP], Li F[SUP]3[/SUP], Zhou J[SUP]4[/SUP], Cai S[SUP]4[/SUP], Liang Y[SUP]5[/SUP], Zhou H[SUP]5[/SUP], Wang X[SUP]6[/SUP], Ren Z[SUP]7[/SUP], Yang J[SUP]8[/SUP].

Author information




Abstract

OBJECTIVES:

To delineate the evolution of CT findings in patients with mild COVID-19 pneumonia.
METHODS:

CT images and medical records of 88 patients with confirmed mild COVID-19 pneumonia, a baseline CT, and at least one follow-up CT were retrospectively reviewed. CT features including lobar distribution and presence of ground glass opacities (GGO), consolidation, and linear opacities were analyzed on per-patient basis during each of five time intervals spanning the 3 weeks after disease onset. Total severity scores were calculated.
RESULTS:

Of patients, 85.2% had travel history to Wuhan or known contact with infected individuals. The most common symptoms were fever (84.1%) and cough (56.8%). The baseline CT was obtained on average 5 days from symptom onset. Four patients (4.5%) had negative initial CT. Significant differences were found among the time intervals in the proportion of pulmonary lesions that are (1) pure GGO, (2) mixed attenuation, (3) mixed attenuation with linear opacities, (4) consolidation with linear opacities, and (5) pure consolidation. The majority of patients had involvement of ≥ 3 lobes. Bilateral involvement was more prevalent than unilateral involvement. The proportions of patients observed to have pure GGO or GGO and consolidation decreased over time while the proportion of patients with GGO and linear opacities increased. Total severity score showed an increasing trend in the first 2 weeks.
CONCLUSIONS:

While bilateral GGO are predominant features, CT findings changed during different time intervals in the 3 weeks after symptom onset in patients with COVID-19.
KEY POINTS:

• Four of 88 (4.5%) patients with COVID-19 had negative initial CT. • Majority of COVID-19 patients had abnormal CT findings in ≥ 3 lobes. • A proportion of patients with pure ground glass opacities decreased over the 3 weeks after symptom onset.



KEYWORDS:

Coronavirus; Pneumonia; Tomography


PMID:32291502DOI:10.1007/s00330-020-06823-8
 
Back
Top